TI
AQST icon

Trexquant Investment’s Aquestive Therapeutics AQST Stock Holding History

Trexquant Investment’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-523,334
Closed -$3.38M – 1742
2025
Q4 		$3.38M Buy
+523,334
New +$3.26M 0.03% 770
2021
Q2 		– Sell
-10,227
Closed -$53K – 1074
2021
Q1 		$53K Buy
+10,227
New +$54.4K ﹤0.01% 1073
2020
Q1 		– Sell
-22,344
Closed -$130K – 1083
2019
Q4 		$130K Buy
+22,344
New +$116K 0.01% 964
2019
Q2 		– Sell
-12,912
Closed -$89K – 789
2019
Q1 		$89K Buy
+12,912
New +$90.5K 0.01% 936

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trexquant Investment's AQST Position: Q1 2026 in Review

Trexquant Investment sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 523,334 shares — an estimated $3.38M sold.

Trexquant Investment first reported a position in AQST in Q1 2019 and held it in 4 quarters. The position peaked at $3.38M in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Trexquant Investment reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 523,334 Aquestive Therapeutics shares in Q1 2026, an estimated $3.38M.
  • Trexquant Investment first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 4 quarters.
  • Trexquant Investment's Aquestive Therapeutics position peaked at $3.38M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.